TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Genmab A/S
Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

Genmab will host a virtual R&D Update and ASH Data Review Meeting on December 11, 2025, presenting recent research and development insights in antibody therapeutics for cancer and serious diseases.

Insights
SNDK   positive

Gained 13.77% after Q1 results exceeded expectations and provided strong Q2 guidance


GMAB   positive

The company is showcasing its ongoing research, highlighting innovative antibody technology platforms, and presenting data from clinical trials, indicating strong progress and potential in developing advanced medical treatments